Subcellular localization of alpha-synuclein aggregates and their interaction with membranes

被引:59
作者
Miraglia, Fabiana [1 ,2 ]
Ricci, Alessio [1 ]
Rota, Lucia [1 ]
Colla, Emanuela [1 ]
机构
[1] Scuola Normale Super Pisa, Bio SNS Lab, Pisa, Italy
[2] Univ Pisa, Dept Pharm, Pisa, Italy
关键词
alpha-synuclein; oligomers; aggregates; subcellular localization; membranes binding; Parkinson's disease; neurodegeneration; alpha-synucleinopathies; FAMILIAL PARKINSONS-DISEASE; TRANSGENIC MICE; IN-VIVO; SYNAPTIC-TRANSMISSION; ALZHEIMERS-DISEASE; LINKED MUTATIONS; MAMMALIAN-CELLS; BRAIN PATHOLOGY; OLIGOMERS; BINDING;
D O I
10.4103/1673-5374.235013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
For more than a decade numerous evidence has been reported on the mechanisms of toxicity of alpha-synuclein (alpha S) oligomers and aggregates in alpha-synucleinopathies. These species were thought to form freely in the cytoplasm but recent reports of alpha S multimer conformations when bound to synaptic vesicles in physiological conditions, have raised the question about where alpha S aggregation initiates. In this review we focus on recent literature regarding the impact on membrane binding and subcellular localization of alpha S toxic species to understand how regular cellular function of alpha S contributes to pathology. Notably alpha S has been reported to mainly associate with specific membranes in neurons such as those of synaptic vesicles, ER/Golgi and the mitochondria, while toxic species of alpha S have been shown to inhibit, among others, neurotransmission, protein trafficking and mitochondrial function. Strategies interfering with alpha S membrane binding have shown to improve alpha S-driven toxicity in worms and in mice. Thus, a selective membrane binding that would result in a specific subcellular localization could be the key to understand how aggregation and pathology evolves, pointing out to alpha S functions that are primarily affected before onset of irreversible damage.
引用
收藏
页码:1136 / 1144
页数:9
相关论文
共 99 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease [J].
Appel-Cresswell, Silke ;
Vilarino-Guell, Carles ;
Encarnacion, Mary ;
Sherman, Holly ;
Yu, Irene ;
Shah, Brinda ;
Weir, David ;
Thompson, Christina ;
Szu-Tu, Chelsea ;
Trinh, Joanne ;
Aasly, Jan O. ;
Rajput, Alex ;
Rajput, Ali H. ;
Stoessl, A. Jon ;
Farrer, Matthew J. .
MOVEMENT DISORDERS, 2013, 28 (06) :811-813
[3]   Alpha-synuclein mRNA expression in oligodendrocytes in MSA [J].
Asi, Yasmine T. ;
Simpson, Julie E. ;
Heath, Paul R. ;
Wharton, Stephen B. ;
Lees, Andrew J. ;
Revesz, Tamas ;
Houlden, Henry ;
Holton, Janice L. .
GLIA, 2014, 62 (06) :964-970
[4]   α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation [J].
Bartels, Tim ;
Choi, Joanna G. ;
Selkoe, Dennis J. .
NATURE, 2011, 477 (7362) :107-U123
[5]   Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease [J].
Bellucci, Arianna ;
Navarria, Laura ;
Zaltieri, Michela ;
Falarti, Elisa ;
Bodei, Serena ;
Sigala, Sandra ;
Battistin, Leontino ;
Spillantini, MariaGrazia ;
Missale, Cristina ;
Spano, PierFranco .
JOURNAL OF NEUROCHEMISTRY, 2011, 116 (04) :588-605
[6]   Interaction of α-synuclein with divalent metal ions reveals key differences:: A link between structure, binding specificity and fibrillation enhancement [J].
Binolfi, Andres ;
Rasia, Rodolfo M. ;
Bertoncini, Carlos W. ;
Ceolin, Marcelo ;
Zweckstetter, Markus ;
Griesinger, Christian ;
Jovin, Thomas M. ;
Fernandez, Claudio O. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (30) :9893-9901
[7]   Structural and functional characterization of two alpha-synuclein strains [J].
Bousset, Luc ;
Pieri, Laura ;
Ruiz-Arlandis, Gemma ;
Gath, Julia ;
Jensen, Poul Henning ;
Habenstein, Birgit ;
Madiona, Karine ;
Olieric, Vincent ;
Boeckmann, Anja ;
Meier, Beat H. ;
Melki, Ronald .
NATURE COMMUNICATIONS, 2013, 4
[8]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[9]   Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour [J].
Breda, Carlo ;
Nugent, Marie L. ;
Estranero, Jasper G. ;
Kyriacou, Charalambos P. ;
Outeiro, Tiago F. ;
Steinert, Joern R. ;
Giorgini, Flaviano .
HUMAN MOLECULAR GENETICS, 2015, 24 (04) :1077-1091
[10]   Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation [J].
Buell, Alexander K. ;
Galvagnion, Celine ;
Gaspar, Ricardo ;
Sparr, Emma ;
Vendruscolo, Michele ;
Knowles, Tuomas P. J. ;
Linse, Sara ;
Dobson, Christopher M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (21) :7671-7676